Table 4.
Diagnostic performance of multiple imaging modalities in breast lymph nodes
Author Year | Accrual period | Subject number of research | Mammogra phy | US | MRI | PET | ||
---|---|---|---|---|---|---|---|---|
(Zhang, et al. 2015) | 2010–2011 | 1.049 breast cancers | - | SE=69.4:SP=81.8:Accuracv=77 | - | - | ||
(Xin. et al. 2014) | 2012–2013 | 323 female primary breast cancer |
SE=35.6;SP=98.9:PPV=35.6;NPV=68.3 | |||||
(Alvarez, et al. 2006) | 1980–2004 | Meta analysis with Sixteen articles |
Cnterion | Non-palpable | Palpable +non- palpable | - | - | |
size<5 mm | SE=48.8–87.7 SP=55.6–97.3 |
SE=66.1–72.7
SP=44.1–97.9 |
||||||
morphology | SE=26.4–75.9 SP=SS.4–98.l |
SE=54.7–92.3 SP=S0.4-87.1 |
||||||
(Valente, et al. 2012) | 200S-2010 | 244 invasive breast carcinomas | SE=21 SP= 99.5 |
SE=43.5 SP= 96.2 |
SE=37.1 SP= 96.7 |
- | ||
(Heusner. et al. 2009) | 2007–2008 | 61 patients with breast cancer | FDG PET/CT SE=5S;SP=92 PPV=82;NPV=77 Accuracy=79 |
|||||
(Kvistad. et al. 2000) | 1998 | 65 patients with invasive breast cancer | SE=83 SP= 90 Accuiac=88 |
|||||
(Lind. et al. 2004) | Review of 1989– 2004 | 201 | For local récurrence, lymph node métastasés and distant métastasés SE =96%:SP = 77% |
|||||
(Song, et al. 2015) | 2008-2012 | 86 invasive breast cancer | SE = 36.4 SP =S6.8 |
SE = 61.4 SP =92.1 |
SE = 61.4 SP =73.7 |
FDG-PET SE = 47.7; SP =81.6 |
||
(Heusner. et al. 2008) | 40 women with suspected breast cancer | 18F-FDG PET/CT SE = 0.80 |
||||||
(An. et al. 2015) | 2008-2012 | 37 patients with breast cancer. For internal
mammary LN metastasis |
Initial US SE=76.6 Initial US combined with SLUS SE=96.7 |
SE=92.9 |